BMP2 and glioblastoma: Studies have shown that synthetic BMP-2 mimetic peptides induce differentiation of glioblastoma stem cells (GSCs) (16), and enhance GSC sensitivity to TMZ treatment by destabilizing HIF-1 (17, 18).